Call +44 800 9755 164

Public tenders for financial in Manchester United Kingdom

Find all Financial tenders in the world.
Finding business opportunities has never been easier.

Results for financial. Make a new search!

Financial and insurance services

Greater Manchester Evergreen 2 Limited Partnership | Published February 15, 2017  -  Deadline March 15, 2017
cpvs
66000000, 66100000

This procurement process is being run jointly by the 3 contracting authorities referred to in Section I.

This procurement process is split into 2 lots:

Lot 1 — relates to the provision of Services to the Evergreen and Evergreen 2 sub-funds; and

Lot 2 — relates to the provision of Services to the Low Carbon sub-fund.

The sub-fund sizes based on currently available funds are 60 000 000 GBP for Evergreen, 45 000 000 GBP for Evergreen 2 and 15 000 000 GBP for Low Carbon. However, the sub-fund size and scope of the Services may expand and/or contract over the term of the contract(s) to reflect changes to the funding that is made available. Such changes may include increases of up to a maximum 100 % of the currently available funds (up to 120 000 000 GBP for Evergreen, 90 000 000 GBP for Evergreen 2 and 30 000 000 GBP for Low Carbon).

The contract includes (but not limited to):

— developing the pipeline of potential projects, following the origination of potential projects from public sector partners and the successful tenderer's own network of contacts;

— monitoring compliance and risk in accordance with accountability requirements and the eligibility rules applicable to the sub-funds;

— registering and publishing all notices, statements or other instruments as may be required in relation to the sub-funds;

— maintaining the sub-funds' financial accounting books, records keeping and perform all other day-to-day operations;

— developing an investment policy and business plan for the sub-funds;

— managing the existing Evergreen portfolio to ensure the achievement of eligible expenditure, output and financial return targets;

— implementing appropriate operational decision making bodies and governance checks and balances; and

— recommending and managing appropriate exit strategies from relevant investments.

The contract includes (but are not limited to):

— developing the pipeline of potential projects, following the origination of potential projects from public sector partners and the successful tenderer's own network of contacts;

— monitoring compliance and risk in accordance with accountability requirements and the eligibility rules applicable to the sub-fund;

— registering and publishing all notices, statements or other instruments as may be required in relation to the sub-fund;

— maintaining the sub-fund's financial accounting books, records keeping and perform all other day-to-day operations;

— developing an investment policy and business plan for the sub-fund;

— implementing appropriate operational decision making bodies and governance checks and balances; and

— recommending and managing appropriate exit strategies from relevant investments.

Blood analysis services

The Christie NHS Foundation Trust | Published February 11, 2017  -  Deadline March 17, 2017
cpvs
85111810, 33141510, 33141570, 33194220, 33696200, 38434520

The Christie NHS Foundation Trust is a tertiary cancer centre, based in Manchester. We provide world renowned clinical services for our patients, first class education of cancer professionals and our clinical trials unit is recognised as a leading centre in Europe. We are the lead cancer centre for a network of services serving 3 200 000 people across Greater Manchester and Cheshire. We also provide some highly specialised services for patients across the UK. Our vision is to continue to deliver top quality cancer care whilst maintaining financial sustainability and demonstrating excellent clinical outcomes

The Trust requires a supplier to provide Histocompatibility and Immunogenetic Services.

The Trust requires a supplier to provide Histocompatibility and Immunogenetic Services to the Trust.

The Haematology and Transplant Unit at The Christie is one of the largest centres in the country specialising in the treatment of haematological malignancies. The unit sees in excess of 7 000 outpatient cases and 1 800 inpatient/day case episodes per year.

Established in 1982, The Stem Cell Transplant Programme now performs over 120 transplants a year for both NHS and private patients. We initially achieved full accreditation with the Joint Accreditation Committee for ISCT and EBMT (JACIE) in 2009, and successfully obtained re-accreditation in May 2016.

The Supply of Histocompatibility and Immunogenetic Services

The Christie NHS Foundation Trust | Published February 13, 2017  -  Deadline March 17, 2017
cpvs
85111810

The Christie NHS Foundation Trust is a tertiary cancer centre, based in Manchester. We provide world renowned clinical services for our patients, first class education of cancer professionals and our clinical trials unit is recognised as a leading centre in Europe. We are the lead cancer centre for a network of services serving 3.2 million people across Greater Manchester and Cheshire. We also provide some highly specialised services for patients across the UK. Our vision is to continue to deliver top quality cancer care whilst maintaining financial sustainability and demonstrating excellent clinical outcomes The Trust requires a supplier to provide Histocompatibility and Immunogenetic Services.
  • 1